Related by context. All words. (Click for frequent words.) 72 QALY 65 QALY gained 64 QALE 62 ratio ICER 61 HbA1C levels 60 postoperative mortality 60 nonfasting triglyceride levels 59 sociodemographic factors 59 peak VO2 58 HRQL 58 MMSE scores 58 MMSE score 58 HbA 1c levels 58 comorbid illnesses 57 antidiabetic medication 57 glycated hemoglobin levels 57 CI -#.# 56 statistical significance p 56 % Confidence Interval 56 PSA nadir 56 per QALY gained 56 postoperative pulmonary 56 CPAP adherence 56 mmHg diastolic 56 cranial irradiation 56 oncologic outcomes 56 inhospital mortality 55 preoperative PSA 55 Score DAS# 55 EDSS scores 55 HbA1C 55 baseline HbA1c 55 % CI #.#-#.# [008] 55 low dose Iluvien 55 perioperative mortality 55 conditional logistic regression 55 HOMA IR 55 DALYs 55 logistic regression model 55 venous thromboembolic disease 55 multivariable analysis 55 multivariable adjusted 55 confidence interval #.#-#.# 54 inhospital 54 glycated hemoglobin HbA1c 54 hypertension diabetes mellitus 54 baseline LDH 54 % CI #.#-#.# [003] 54 odds ratios ORs 54 atorvastatin #mg 54 HRQoL 54 hydroxyvitamin D levels 54 methotrexate monotherapy 54 beta blocker therapy 54 myocardial viability 54 dose dabigatran 54 logistic regression analysis 54 HbA1c levels 54 ADCS ADL 54 endometrial thickness 54 interobserver reliability 54 CDAI score 54 univariate analyzes 54 oxycodone CR 54 SGRQ 54 P ≤ 54 CHD mortality 54 arterial oxygen saturation 54 dose atorvastatin 54 % CI #.#-#.# [006] 54 postintervention 53 #.#ng/ml 53 mmHg p = 53 dose Iluvien 53 mortality morbidity 53 leukocyte count 53 Triglyceride levels 53 IBDQ 53 mL/min/#.# m 2 53 EuroSCORE 53 pCR 53 hemoglobin A1c HbA1c 53 CVD mortality 53 recurrent venous thromboembolism 53 Hb A1C 53 psychiatric comorbidities 53 ICD therapy 53 thyrotropin levels 53 preintervention 53 MADRS score 53 confidence intervals CIs 53 EDSS score 53 HRQOL 53 lymphocyte count 53 postoperative morbidity 53 PASI scores 53 sociodemographic characteristics 53 NIH CPSI 53 postoperative complication 53 A1c levels 53 placebo p 53 treat NNT 53 colorectal adenoma 53 LAGB 53 adverse perinatal 53 ALND 53 oral anticoagulant therapy 53 nondepressed 53 aldosterone antagonist 53 statistically significant p = 53 posttreatment 53 CI #.#-#.# [002] 53 depressive symptomatology 53 Operative mortality 53 medication nonadherence 53 NIHSS score 53 albumin excretion rate 53 baseline A1C 53 noncardiac 53 BMI z 53 morphometric vertebral fractures 53 clodronate 52 nondiabetic patients 52 reinfarction 52 abstinent alcoholics 52 plasma triglycerides 52 postoperative infections 52 neurodevelopmental impairment 52 Logistic regression 52 colorectal neoplasia 52 NIHSS 52 #OHD 52 intact parathyroid hormone 52 noncancer 52 echocardiographic parameters 52 ELBW infants 52 β blockers 52 cardio respiratory fitness 52 sleeve lobectomy 52 HbA 1c 52 Preterm infants 52 nonsignificant difference 52 revascularization procedures 52 #.#/#.# mmHg [001] 52 elevated triglyceride levels 52 mesalamine granules 52 annualized relapse 52 Non inferiority 52 mRS 52 sensitivity specificity 52 CI #.#-#.# [001] 52 serum urate 52 clinically localized prostate 52 neurodevelopmental outcomes 52 adenoma detection 52 p = #.# [003] 52 % CI #.#-#.# [004] 52 nonvertebral fracture 52 HAQ DI 52 meta analytic 52 dietary folate intake 52 prevalences 52 symptomatic intracranial hemorrhage 52 invasive prenatal 52 plasma cortisol 52 biochemical recurrence 52 estimated GFR 52 serum PSA 52 adenoma recurrence 52 hemoglobin A1c levels 52 SUVmax 52 hip BMD 52 serum lipid levels 52 femoral neck BMD 52 p = .# [002] 52 DAS# scores 52 Breslow thickness 52 μmol L 52 EORTC QLQ C# 52 carotid stenosis 52 lumbar spine BMD 52 Apgar scores 51 comorbidity 51 confidence interval CI 51 perioperative morbidity 51 morbidity mortality 51 placebo p = 51 pulmonary dysfunction 51 postdischarge 51 EQ 5D 51 pulmonary exacerbations 51 oral anticoagulation 51 urinary albumin excretion 51 carotid IMT 51 NNT = 51 mIU ml 51 recurrent VTE 51 HbA 1C 51 VLBW infants 51 fasting triglyceride levels 51 MDRD equation 51 neutrophil counts 51 parous women 51 serum creatinine levels 51 antioxidant supplementation 51 perinatal outcomes 51 creatinine ratio 51 Radical prostatectomy 51 lipid lowering agents 51 Hazard Ratio HR 51 NSTE ACS 51 chronic hemodialysis 51 binary restenosis 51 PSADT 51 + PH# 51 obstructive CAD 51 Readmissions 51 euthymic patients 51 R0 resection 51 serum estradiol 51 undergoing bariatric surgery 51 ejection fractions 51 platelet reactivity 51 multivariate Cox 51 QTcF 51 percutaneous vertebroplasty 51 P = .# 51 Ishak fibrosis score 51 Insulin sensitivity 51 DLQI 51 angiographic outcomes 51 sustained virological response 51 nonoperative treatment 51 WOMAC pain 51 Viral load 51 acid suppressive medication 51 logistic regression models 51 symptom exacerbation 51 inflammatory biomarkers 51 C diff infections 51 HBeAg seroconversion 51 Montgomery Asberg Depression 51 -#.# mg dL [001] 51 LS BMD 51 sociodemographic variables 51 tertiles 51 Homocysteine levels 51 interquartile range 50 pg ml 50 FeNO 50 nonpharmacologic 50 CK # plasma concentrations 50 homocysteine concentrations 50 comorbidities 50 highest quintile 50 sd = 50 colorectal cancer incidence 50 refractory ischemia 50 mmol l 50 Scale EDSS score 50 nonfatal MI 50 guideline concordant 50 beta carotene supplementation 50 TAVR 50 albumin excretion 50 glycemic variability 50 complete cytogenetic response 50 fragility fracture 50 troponin T 50 patients undergoing CABG 50 rho = 50 CORE OM 50 virological response 50 % CI #.#-#.# [007] 50 urine albumin 50 hemorrhagic complications 50 myocardial reperfusion 50 PSA velocity 50 hsCRP levels 50 glomerular filtration rate 50 RBP4 levels 50 plasma homocysteine levels 50 nonadherence 50 pulmonary capillary wedge 50 HF hospitalization 50 % CI #.#-#.# [002] 50 comorbid conditions 50 serum sodium 50 neurocognitive function 50 salmeterol fluticasone propionate 50 subtrochanteric 50 univariate 50 triacylglycerol concentrations 50 definite stent thrombosis 50 noncardiovascular mortality 50 Crohn Disease Activity 50 allele frequencies 50 NYHA functional class 50 Kaplan Meier analysis 50 atherogenic dyslipidemia 50 ECD kidneys 50 serum selenium 50 postoperative chemotherapy 50 magnesium intake 50 biochemical relapse 50 hemoglobin A1c 50 nocturnal hypoglycaemia 50 Adjuvant chemotherapy 50 Cronbach alpha 50 AUA Symptom Score 50 MetS 50 adenotonsillectomy 50 multivariable analyzes 50 A1Cs 50 advanced neoplasia 50 p = .# [001] 50 virologic suppression 50 Hazard Ratio 50 anthropometric measures 50 -#.# ± [002] 50 shorter telomere length 50 DSM IV diagnosis 50 serum concentrations 50 nmol L. 50 systolic BP 50 T1DM 50 nonobese 50 diastolic pressures 50 singleton babies 50 CHADS2 50 Kaplan Meier method 50 LV dysfunction 50 generalized estimating 50 MACCE 50 CHD CVD 50 HpSA 50 psychiatric comorbidity 50 chemoradiation therapy 50 Expanded Disability Status 50 -#.# log# 50 oxygen saturations 50 glycosylated hemoglobin levels 50 hemostatic efficacy 50 coronary revascularization procedures 50 radical retropubic prostatectomy 50 FFR guided treatment 50 mean baseline A1C 50 Kaplan Meier 50 IOP lowering 50 atrophic gastritis 50 amoxicillin clavulanate 50 oral prednisolone 50 arterial thickening 50 hemoglobin concentrations 50 multivariable Cox 50 asymptomatic carotid stenosis 50 Pain Intensity 50 oophorectomy 50 MELD score 50 maternal morbidity 49 antipsychotic prescribing 49 oxycodone IR 49 polyp recurrence 49 waist girth 49 endpoint assays 49 tHcy concentrations 49 uncorrected visual acuity 49 MDRD 49 androgen suppression 49 chorioamnionitis 49 dose pravastatin 49 mean baseline HbA1c 49 cardiovascular hospitalizations 49 ARB telmisartan 49 extracolonic findings 49 corticosteroid dose 49 mL/min/#.# m2 49 preoperative chemotherapy 49 HoLEP 49 #mg/dL [001] 49 Calorie intake 49 MELD scores 49 intima media thickness 49 serum sodium levels 49 serum clusterin levels 49 antithrombotic therapy 49 cardiopulmonary diseases 49 epidural analgesia 49 Reynolds Risk Score 49 serum testosterone 49 paricalcitol 49 mU L 49 metabolic parameters 49 liver histology 49 retrospective cohort 49 RYGB 49 lowest tertile 49 Index CDAI 49 haemorrhagic stroke 49 umol L 49 colonoscopic 49 APOE genotype 49 warfarin therapy 49 Secondary endpoints include 49 hippocampal volume 49 5-FU/LV 49 TT genotype 49 p = NS 49 cerebral oxygenation 49 prepregnancy weight 49 estimated glomerular filtration 49 nonsignificant 49 orchiectomy 49 certolizumab 49 recurrent tonsillitis 49 Fasting glucose 49 symptomatic carotid stenosis 49 HIV HCV coinfected 49 undergo bariatric surgery 49 hemodialysis patients 49 Poisson regression 49 serum testosterone levels 49 attain statistical significance 49 ovulatory cycles 49 BMS p = 49 apnea hypopnea index 49 multivariate regression 49 systolic blood pressures 49 colonic polyps 49 covariate 49 Cardiorespiratory fitness 49 QoL 49 serum HBV DNA 49 statistically significant p 49 thromboprophylaxis 49 death reinfarction 49 nonfatal myocardial infarction 49 radical nephrectomy 49 ximelagatran 49 psychiatric morbidity 49 atheroma volume 49 Zevalin consolidation 49 AOR = 49 mTSS 49 posttransplant 49 psychosocial functioning 49 FDA defined valvulopathy 49 metabolic syndrome MetS 49 PSA kinetics 49 locoregional 49 multiple logistic regression 49 peak plasma concentrations 49 serum cotinine levels 49 pmol L 49 CsA 49 lifetime abstainers 49 μg dL 49 multivariate analyzes 49 β = 49 androgen deprivation 49 p ≤ 49 postoperative delirium 49 anastomotic leak 49 lung resection 49 serum bilirubin 49 receiving VICTRELIS 49 hematologic parameters 49 randomized controlled trials RCTs 49 Fasting glucose levels 49 VO2 peak 49 multivariate regression analysis 49 -#.# mg dL [002] 49 serum PTH 49 external beam radiotherapy 49 pancreatic resection 49 Coronary Artery Bypass Graft 49 NHANES III 49 Charlson comorbidity index 49 ECLS 49 Hazard Ratio = 49 postoperative infection 49 highest tertile 49 conventional angiography 49 transaminase levels 49 perioperative complications 49 Complication rates 49 RVUs 49 cecal intubation 49 triglyceride concentrations 49 euthyroid 49 Sharpe Ratio 49 somatoform disorders 49 visceral adiposity 48 Stomach stapling 48 Bonferroni correction 48 premenopausal breast cancer 48 underwent CABG 48 spirometric 48 urinary cadmium 48 ATACAND 48 BMI ≥ 48 severe hypoglycaemia 48 artery calcification 48 Cystatin C 48 logistic regression analyzes 48 PCWP 48 drank pomegranate juice 48 corneal astigmatism 48 nonoperative 48 left ventricular systolic 48 prepregnancy BMI 48 Primary endpoints 48 abdominal circumference 48 psychosocial variables 48 Moderately obese 48 oral diclofenac 48 venous thromboembolism prophylaxis 48 laparoscopic banding 48 procalcitonin 48 mmol L. 48 hypofractionated radiation 48 covariates 48 PANSS scores 48 PaO 2 48 glomerular filtration 48 #.#mmol L [002] 48 subscale scores 48 malabsorptive 48 tertile 48 hepatic fat 48 logistic regression 48 Rectal cancer 48 symptomatic intracerebral hemorrhage 48 Multivariate analysis 48 HDRS 48 serum parathyroid hormone 48 regression coefficient 48 mIU L 48 kg m² 48 mutated K ras 48 serum calcium 48 polyp detection 48 Hip fracture 48 BCG vaccinated 48 ALT elevation 48 covariance 48 preterm deliveries 48 Secondary endpoints included 48 adjuvant radiation 48 symptom severity 48 birthweight babies 48 hemodynamic parameters 48 adenoidectomy 48 neurodevelopmental outcome 48 VLBW 48 adenomatous polyps 48 % CI #.#-#.# [001] 48 transferrin saturation 48 β blocker 48 #.#mmHg 48 HSMR 48 arterial stiffening 48 LDB CPR 48 serum phosphate 48 multivariable logistic regression 48 ejaculatory function 48 anticoagulation therapy 48 mm Hg diastolic 48 SpHb monitoring 48 thoracoscopic lobectomy 48 ADCS CGIC 48 hip fracture 48 CYP#D# genotype 48 #OHD levels 48 urinary cortisol 48 pg mL 48 chronic rhinosinusitis 48 affective psychosis 48 Rating Scale BPRS 48 systolic dysfunction 48 non aspirin NSAIDs 48 racemic albuterol 48 #.#-#.# [011] 48 RfD 48 lopinavir r arm 48 OPCAB 48 coronary revascularization 48 CR nPR 48 = #.#-#.# 48 serologically active patients 48 hematopoietic cancers 48 salpingo oophorectomy 48 infliximab monotherapy 48 IR Cysteamine 48 metabolite concentrations 48 extrapyramidal symptoms 48 testosterone supplementation 48 neonatal morbidity 48 Baseline characteristics 48 Scale EDSS 48 dyslipidaemia 48 symptomatic hyponatremia 48 gallstone disease 48 oncological outcomes 48 androgen depletion 48 hydroxyvitamin D concentrations 48 elevated LDL cholesterol 48 Moderate drinkers 48 LVEF 48 TPV r 48 CDI recurrence 48 CCyR 48 premorbid 48 macroalbuminuria 48 tamoxifen Nolvadex ® 48 CIN3 48 #q# deletion syndrome 48 triglyceride concentration 48 Colorectal cancer incidence 48 blood glucose concentrations 48 care regimens CCR 48 weaning weights 48 preserved ejection fraction 48 Coronary artery bypass graft 48 Depressive symptoms 48 CaPre TM 48 ventricular enlargement 48 tumor histology 48 HAART initiation 48 selenium intake 48 everolimus eluting stents 48 interrater reliability 48 lobular cancer 48 UPPP 48 urinary albumin 48 exhaled nitric oxide 48 Logistic regression analysis 48 hemoglobin A1C 48 bariatric surgical 48 Renal dysfunction 48 endarterectomy 48 glycated hemoglobin 48 EXJADE 48 debulking surgery 48 nonvertebral fractures 48 OAB symptoms 48 Arch Intern Med 48 hypertensives 48 conjugated equine estrogen 48 multivariate logistic regression 48 invasive aspergillosis 48 postprocedure 48 intraobserver 48 periprocedural 48 #-#,# mg 48 transaminase elevations greater 48 thromboembolism 48 FOLFIRI alone 48 interobserver 48 YMRS 48 QVAR R 48 fetal malformations 47 serum aminotransferase levels 47 neurologic complications 47 fractional anisotropy 47 MitraClip device 47 suicide attempters 47 erection hardness 47 dietary calcium intake 47 persistency mortality 47 nondiabetics 47 underwent bariatric surgery 47 APACHE II 47 serum vitamin D 47 birthweight 47 nonischemic cardiomyopathy 47 C. difficile colitis 47 Suicidal ideation 47 CTEPH 47 Drug eluting stent 47 Platelet counts 47 pharmacodynamic parameters 47 Multivariate logistic regression 47 urinary excretion 47 GH deficient 47 aspartate aminotransferase AST 47 Heavy menstrual bleeding 47 % CI #.#-#.# [005] 47 aromatase inhibitor therapy 47 singleton pregnancy 47 BEXXAR Therapeutic Regimen 47 ADAS cog 47 tic severity 47 Secondary endpoints 47 nonselective NSAIDs 47 cervical spine fractures 47 comorbid disorders 47 adjuvant therapies 47 BRCA2 mutation carriers 47 microg 47 obese adolescents 47 DHEA supplementation 47 Case persistency 47 aged ≥ 47 lipid lowering therapy 47 carotid artery stenting CAS 47 IPSS 47 DEXA scans 47 μg L 47 ICD implants 47 dysglycemia 47 serum IGF 47 osteoporotic fracture 47 CIN3 + 47 IFL chemotherapy regimen 47 FluCAM arm 47 Rating Scale MADRS 47 axillary node dissection 47 neurologic impairment 47 cardiorespiratory fitness 47 prostate cancer CaP 47 adrenal function 47 symptomatic VTE 47 baseline FEV 47 nonmelanoma skin cancers 47 telomere lengths 47 comorbid depression 47 singleton births 47 hepatorenal syndrome 47 alteplase 47 eGFR 47 STN stimulation 47 Recurrent Stroke 47 observational cohort 47 PANSS total 47 coronary CTA 47 CI = 47 CK MB 47 Zometa hazard 47 International Prostate Symptom 47 antibiotic regimens 47 RE LY ® 47 extrapyramidal side 47 HBeAg 47 urolithiasis 47 antiplatelet therapies 47 mmHg systolic 47 renal cell carcinomas 47 spontaneous preterm delivery 47 ofpatients 47 prospectively stratified 47 postop 47 TKAs 47 tHcy 47 proportional hazards 47 aOR 47 fin div 47 neurologic sequelae 47 mg BID dose 47 Renal Cell Carcinoma RCC 47 Flexi Scope 47 subfertility 47 airflow obstruction 47 bivalirudin monotherapy 47 hepatic insulin sensitivity 47 NNRTI resistance 47 femoral neck fracture 47 dichotomized 47 aldosterone antagonists 47 serum uric acid 47 myocardial infarctions MIs 47 nonfatal stroke 47 testosterone secretion 47 incomplete revascularization 47 Decitabine 47 Index CDAI score 47 antibiotic prescribing 47 nonpregnant women 47 binary logistic regression 47 inpatient hospitalizations 47 nighttime awakenings 47 COPD exacerbation 47 carotid artery blockage 47 recurrent wheezing 47 antibody titer 47 macrovascular events 47 SHBG levels 47 bioprosthetic valve 47 perinatal mortality 47 mL kg 47 dose statin therapy 47 birthweights 47 adiponectin concentrations 47 titrated glipizide plus 47 radioiodine therapy 47 CDAI 47 aminotransferases 47 univariate analysis 47 rehospitalization 47 Kay Tee Khaw 47 Sleep disturbances 47 BRCA gene mutations 47 subthreshold depression 47 ADAS Cog 47 testicular tumors 47 multivariate adjustment 47 cerebral somatic oximeter 47 lipid lowering medication 47 precancerous cervical 47 Carotid artery stenting 47 stepwise logistic regression 47 pharmacologic treatments 47 IFN alfa 47 warfarin dosage 47 meta regression 47 neurologic outcomes 47 nadroparin 47 Vectibix monotherapy 47 obstructive coronary artery 47 atherosclerotic renal artery stenosis 47 BMI percentiles 47 mmol L 47 fragility fractures 47 creatinine clearance CrCl 47 CHD coronary 47 hemoglobin Hb 47 recurrent myocardial infarction 47 gestational diabetes mellitus GDM 47 Neuropsychiatric Inventory 47 pharmacological therapies 47 Munghana Lonene Listenership 47 serum magnesium 47 residual platelet reactivity 47 mGy 47 6MWD 47 Skin sterol 47 AUCs 47 upper gastrointestinal bleeding 47 bivariate analyzes 47 VTEs 47 Symptom severity 47 Antiretroviral therapy 47 dosing frequency 47 TOF PET 47 HLA DRB1 SE 47 Socioeconomic status 47 eplerenone 47 folate intakes 47 postoperative radiotherapy 47 Cardiopulmonary bypass 47 empyema 47 mammographic density 47 nulliparous women 46 lobular involution 46 sievert 46 recurrent UTI 46 vitamin D sufficiency 46 patient centeredness 46 calculated creatinine clearance 46 postoperative AF 46 folate concentrations 46 liver biopsies 46 osteoporotic vertebral fractures 46 lipid lowering medications 46 thrombocytopenic 46 WHIP Pitcher 46 biopsied breast 46 postoperative complications 46 Caesarean deliveries 46 drank decaffeinated coffee 46 Kaplan Meier survival 46 comorbid diagnoses 46 prolactin levels 46 nasal symptom 46 Descriptive statistics 46 carotid bruit 46 Prostate specific antigen 46 nocturnal hypoglycemia 46 retinal thickness 46 LDL triglycerides 46 hemodynamics 46 therapeutic regimens 46 deciliter 46 clinically meaningful improvements 46 phosphorus binders 46 endometrial hyperplasia 46 depressive symptom 46 Coronary artery bypass 46 venous clots 46 Brief Psychiatric 46 = .# 46 multivariable adjustment 46 Montgomery Åsberg Depression 46 advanced adenoma 46 nephron sparing surgery 46 metastatic lung cancer 46 HNSCC 46 differential gene expression 46 simvastatin #mg 46 curative treatments 46 baseline serum creatinine 46 intracranial stenosis 46 HAM D# 46 BPH Symptom Score 46 ± #.#mm [001] 46 SRBD 46 pulmonary exacerbation 46 cilostazol 46 arterial thromboembolic events 46 unplanned readmissions 46 liver metastasis 46 NT proBNP 46 clinically meaningful reductions 46 lung function 46 oral talactoferrin 46 Stent thrombosis 46 BMPR2 46 de aths 46 IPAH 46 latent celiac disease 46 bioavailable testosterone 46 recurrent ischemia 46 CC genotype 46 hip resurfacing arthroplasty 46 Calcium intake 46 elevated hsCRP 46 x ULN 46 distal colon cancer 46 unmeasured confounders 46 immunosuppression therapy 46 Doxil ® 46 AUC0 #hr 46 aminotransferase levels 46 AMOR IPAT 46 coinfected patients 46 pneumococcal carriage 46 PDP MLR 46 hippocampal volumes 46 salivary cortisol 46 lymphadenectomy 46 spontaneous vaginal 46 anagrelide 46 trivial Klatsky 46 acute cholecystitis 46 noncardiovascular 46 DAS# [002] 46 MRSA bloodstream infection 46 cytoreductive nephrectomy 46 potent antiretroviral therapy 46 PSA screening 46 beta coefficient 46 histological subtype 46 DVT PE 46 untreated OSA 46 QTc intervals 46 antibiotics metronidazole 46 microalbumin test 46 thyroid nodules 46 idraparinux 46 Morbid obesity 46 serum lipid 46 anogenital distance 46 CYPHER ® 46 systemic embolism 46 IVF pregnancies 46 Alzheimer Disease Assessment 46 Charlson Comorbidity Index 46 p = 46 postoperative atrial fibrillation 46 haematologic 46 lignan intake 46 unmeasured confounding 46 cardiometabolic risk 46 Visual acuity 46 SLNB 46 carotid artery narrowing 46 2D 4D ratio 46 #.# = Weighted [003] 46 CYP#D# inhibitor 46 VTE prophylaxis 46 nodal metastases 46 foveal thickness 46 severe exacerbations 46 linaclotide treated 46 adjuvant tamoxifen 46 ICDs implanted 46 gestational hypertension 46 Main Outcome Measure 46 χ 46 Main Outcome Measures 46 perfusion abnormalities 46 cardiovascular hospitalization 46 CIN2 + 46 Cotinine 46 recurrent miscarriage 46 Slome notes 46 hyperbilirubinemia 46 Kidney Disease Outcomes 46 advanced adenomas